Rheumatoid arthritis (RA) is a chronic autoimmune condition that affects millions worldwide. According to the World Health Orgnization, 18 million people worldwide were living with the condition in ...

Discover the reality behind Rheumatoid Arthritis, from its early onset potential to exercise benefits, backed by latest ...

Avtozma, the third biosimilar to Actemra, has received FDA approval for multiple inflammatory diseases and COVID-19, potentially expanding treatment access for patients.